| ADAM10 cleavage of N‐cadherin and regulation of cell–cell adhesion and β‐catenin nuclear signalling K Reiss, T Maretzky, A Ludwig, T Tousseyn, B De Strooper, D Hartmann, ... The EMBO journal 24 (4), 742-752, 2005 | 535 | 2005 |
| Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ... Cancer cell 27 (4), 516-532, 2015 | 285 | 2015 |
| Differential contribution of the three Aph1 genes to γ-secretase activity in vivo L Serneels, T Dejaegere, K Craessaerts, K Horré, E Jorissen, T Tousseyn, ... Proceedings of the National Academy of Sciences 102 (5), 1719-1724, 2005 | 215 | 2005 |
| ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the γ-secretase T Tousseyn, A Thathiah, E Jorissen, T Raemaekers, U Konietzko, K Reiss, ... Journal of Biological Chemistry 284 (17), 11738-11747, 2009 | 192 | 2009 |
| Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 … J Morscio, D Dierickx, J Nijs, G Verhoef, E Bittoun, X Vanoeteren, ... The American Journal of Surgical Pathology 38 (7), 875-886, 2014 | 174 | 2014 |
| Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing F Amant, M Verheecke, I Wlodarska, L Dehaspe, P Brady, N Brison, ... JAMA oncology 1 (6), 814-819, 2015 | 155 | 2015 |
| Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development X Sagaert, E Van Cutsem, G De Hertogh, K Geboes, T Tousseyn Nature reviews Gastroenterology & hepatology 7 (6), 336, 2010 | 127 | 2010 |
| How I treat posttransplant lymphoproliferative disorders D Dierickx, T Tousseyn, O Gheysens Blood, The Journal of the American Society of Hematology 126 (20), 2274-2283, 2015 | 116 | 2015 |
| JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma K Van Roosbroeck, L Cox, T Tousseyn, I Lahortiga, O Gielen, B Cauwelier, ... Blood, The Journal of the American Society of Hematology 117 (15), 4056-4064, 2011 | 112 | 2011 |
| Histological transformation and progression in follicular lymphoma: a clonal evolution study R Kridel, FC Chan, A Mottok, M Boyle, P Farinha, K Tan, B Meissner, ... PLoS medicine 13 (12), e1002197, 2016 | 109 | 2016 |
| JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model S Degryse, CE De Bock, L Cox, S Demeyer, O Gielen, N Mentens, ... Blood, The Journal of the American Society of Hematology 124 (20), 3092-3100, 2014 | 109 | 2014 |
| Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP … RU Trappe, D Dierickx, H Zimmermann, F Morschhauser, P Mollee, ... Journal of Clinical Oncology 35 (5), 536-543, 2017 | 95 | 2017 |
| Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ K Put, A Avau, E Brisse, T Mitera, S Put, P Proost, B Bader-Meunier, ... Rheumatology 54 (8), 1507-1517, 2015 | 95 | 2015 |
| Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a … P Vandenberghe, I Wlodarska, T Tousseyn, L Dehaspe, D Dierickx, ... The Lancet Haematology 2 (2), e55-e65, 2015 | 95 | 2015 |
| PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma M Boi, A Rinaldi, I Kwee, P Bonetti, M Todaro, F Tabbò, R Piva, ... Blood 122 (15), 2683-2693, 2013 | 92 | 2013 |
| Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma-endpoints of a spectrum of one disease? S Hartmann, C Döring, C Jakobus, B Rengstl, S Newrzela, T Tousseyn, ... PloS one 8 (11), e78812, 2013 | 91 | 2013 |
| Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors D Dierickx, T Tousseyn, X Sagaert, S Fieuws, I Wlodarska, J Morscio, ... Leukemia & lymphoma 54 (11), 2433-2440, 2013 | 88 | 2013 |
| Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far? J Morscio, D Dierickx, T Tousseyn Clinical and Developmental Immunology 2013, 2013 | 87 | 2013 |
| Gene expression profiling reveals clear differences between EBV‐positive and EBV‐negative posttransplant lymphoproliferative disorders J Morscio, D Dierickx, JF Ferreiro, A Herreman, P Van Loo, E Bittoun, ... American Journal of Transplantation 13 (5), 1305-1316, 2013 | 87 | 2013 |
| Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching L De Smedt, S Palmans, D Andel, O Govaere, B Boeckx, D Smeets, ... British journal of cancer 116 (1), 58-65, 2017 | 86 | 2017 |
